Acute coronary syndrome (ACS) continues to be a substantial contributor to both morbidity and mortality, withstanding notable evolutions in its prevention and treatment. (1).
Hypercholesterolemia is a known significant risk factor for coronary artery disease. Increased total cholesterol, LDL cholesterol (LDL-C), and non-HDL-Cholesterol (non-HDL-C) are associated with 20 – 30% risk of premature cardiac damage in youth. Hypertriglyceridemia is associated with two-threefold risk of incident and progressive cardiac and structural damage. (1) Lipid-lowering therapy must be initiated immediately after ACS to reduce the risk of recurrent cardiovascular events and mortality. (2) The approach to managing hypercholesterolemia has evolved significantly over the years, emphasizing the need for an aggressive treatment, akin to firing at a target, while also highlighting the importance of long-term vigilance.
Author Sub-editor: Dr Pok-Tin Tang Dr Pok-Tin Tang is an ST5 cardiology registrar in the Thames Valley deanery, currently undertaking a period of out of
Author Sub-editor: Dr May Hu Dr May Hu is a cardiology trainee in the North West deanery. She graduated with First Class Honours from the University
Author Sub-editor: Dr Jhiamluka Solano Dr Jhiamluka Solano is a cardiology resident doctor (ST6) in the Yorkshire and Humber Deanery, currently undertaking a DPhil (PhD)
Author Sub-editor: Dr Joshua Rowland Dr Joshua Rowland is a cardiology registrar working in the North West Deanery. He graduated from the University of Manchester
Author Sub-editor: Dr Atmadeep Banerjee Dr Atmadeep Banerjee is an ST4 Cardiology Registrar in the Kent, Surrey and Sussex deanery. He graduated from Calcutta National
